Here are the biggest calls on Wall Street on Monday: EvercoreISI is an outperform of Evercore ISI, so they repeat Netflix and say the company is attacking all cylinders. “Netflix is the most powerful financial and competitive franchise in streaming, and believes live events and advertising revenue will serve as a new, long-term material growth vector.” Wedbush has repeatedly raised Apple’s price targets, citing strong iPhone 17 demand. “Based on the early powerful demand signs coming out of the iPhone 17 cycle, we are raising our price target from $270 to $310. With the iPhone 17 officially on sale over the weekend, we were amazed at the demand trajectory that appears to have been tracking 10%-15% ahead of the iPhone 16.” Read more. Piper Sandler says he has upgraded Neutral Piper Sandler’s Steven Madden to overweight and is watching “recovery before his peers” from the shoe company. “Upgrade Shoo to Overweight for $40.” Morgan Stanley upgrades ASML from equal weight to overweight. Investment banks are seeing “early signs of improvement” for semiconductor equipment companies. “Since peaking last year (July 24th), ASML’s earnings forecast has been revised significantly downwardly, as typical of stock prices, with a noticeable impact on stock prices (a 45% reduction in peaking to troughs).” Baird adds a fresh pick to Nike Baird, saying Nike is a turnaround story. “A complete positive inflection in market sales will be the last piece in the story, but stocks have been drawn in from late August, likely bottoming out the forward EP, potentially improving calendar-2026 macro conditions, but I love the risk/reward.” Jefferies is launching Iron Mountain as they say they are bullish against the shares of Technology Infrastructure Storage Company. “Iron Mountain is undergoing strategic transformation and accelerating the growth of data centers, digital solutions and overall asset lifecycle management.” Bernstein repeats Nvidia as he says Bernstein’s purchases are sticking to Nvidia’s stock. “The data center opportunities are very large, still early and material benefits are still possible,” Barclays repeats the meta platform. Overweight Barclays says he’s bullish on Meta’s advertising business opportunities. “We’ll see incremental ad revenue of up to $6 billion and $1.9 billion from WhatsApp and threads in ’26 and ’27, respectively,” Bank of America repeats Amazon as Bank of America says it remains bullish with Amazon moving into the grocery business. “Amazon’s entry into grocery has been slow for many years with set-offs, but in June we moved on to YTD with Whole Foods reorganization. Jefferies launched Grid Dynamics with Buy Jefferies, and the digital IT services company is well positioned. “We have set a purchase rating and a price target of $11 at Gdyn, an IT services company focused on digital engineering.” Citi has launched Buy Citi’s Ryder System, and there is more room for operation in its shares in Logistical Transportation Company. “R is the story of a business model transformation that still has a runway for further traction with investors.” Wells Fargo says that Brinker International is too fat from comparable weight and that Fargo should upgrade Brinker, which means investors should buy dips from owners of Chilean and other restaurant brands. “The stock is -13% after fq4. This slows down after fq4, as it alleviates the expected loom and nt data. However, 1) Eat’s FY26 COMP/EPS guide looks beatable, and MGMT vented trust in the ’26 momentum lever (Ribs, MKTG, Queso Lirounown, Ops/Tech, etc.).” Barclays upgrades Helmeric & Payne from equal weight to overweight. “Upgrades HP to OW, raises PT to $25 (from the current $17), representing an upside potential of 22% from current levels.” BMO upgrades Xcel Energy to deliver market performance BMO says there is more room for drives in the energy company’s stock. “We are upgrading XEL stocks from market performance to outperform.” Wells Fargo starts Guardant Health with overweight Wells Fargo, saying he likes the health company’s “oncology-focused strategy.” “We’re overweight and starting $72 in GH.” Piper Sandler repeats Tesla as overweight Piper Sandler is increasing its stock price from $400 to $500 per share. “We’re increasing our price target to $500 following our trip to China. After meeting with the Chinese EV maker, we can see why Elon Musk respects these “fast followers.” Morgan Stanley upgrades the applied materials from equal weight to overweight. Banks say the stocks in the applicable materials are persuasive. “AMAT is currently trading at a 25% discount on the average (LAM Research) since 2023, with the new PT meaning a 15% discount.” Morgan Stanley repeats Micron Technology, with Morgan Stanley increasing its price target from $135 to $160 per share. “Mikron – A global team of insights, highlighted last week’s FAQ, has improved the conditions for most flavors of the drums,” UBS upgrades Factset to buy from neutral, with banks saying investors should buy a dip of stock in capital market systems companies. “FDS is upgrading FDs that we buy from Neutral following our recent sale. We believe that FDS (and the entire information services sector) has been caught up in a negative AI disruption theme that weighs in multiples.” Raymond James cuts Renard from the market to a performance degradation. “Following a review of the results of 3Q25 on Friday, we are downgrading Ren’s rating to underperformance (from market performance). Bank of America repeats Caterpillar as Buy Bank of America rises from $495 to $517 per share. “CAT is a global powerhouse in equipment in mining, construction, oil and gas, rail and power systems.” Citigroup repeats General Motors with Buy Citi increasing from $61 to $75 per share. “GM has the most leverage in aggressive trade agreements for every equity in our compensation capabilities.” Bank of America is launching Aura Minerals with Buy Bank of America. He says this is bullish against the gold miners’ stocks. “We have started compensation for gold miners Aura Minerals (AUGO) with a purchase rating and a $40 share price target (PO) meaning a ~25% increase.” BMO has upgraded Sarepta to perform in the market, with BMO saying its muscular dystrophic drugs are promising. “We believe that Salepta is taking advantage of its (Duchenne muscular dystrophy) expertise and market leadership to set its own way to promote long-term intake of Elevidi and its (morpholino phosphate) franchises.” Truist repeats Alphabet, with Bunk The Bank increasing its price target from $225 to $285 per share. “Even though the new Gen-AI platform is growing users and usage, the company believes it continues to dominate the search market at 90%+, so it remains constructive at Google.”
